Hydromer, Inc. Releases Letter to Shareholders from Chairman Braeden Lichti

in Sep 14, 2023

CONCORD, NC, Sept. 14, 2023 (GLOBE NEWSWIRE) — via Hydromer Inc. (OTC: HYDI) (“The Company”), a worldwide supplier of specialty coatings and biopolymers for medical devices and industrial applications, announced today the release of a letter to shareholders from its Executive Chairman, Mr. Braeden Lichti. This letter, which is available for viewing at 2023-002.pdf (hydromer.com), offers an[…]

Read more

Hydromer, Inc. Marks a Formidable Presence: Set to Exhibit at BIOMEDevice Conferences in Boston and Santa Clara

in Aug 25, 2023

Hydromer Inc. (OTC: HYDI) (the “Company”), a worldwide supplier of specialty coatings and biopolymers for medical devices and industrial applications, is pleased to announce its attendance with a booth at both BIOMEDevice Boston being held on September 20-21, 2023, in Boston, MA, and BIOMEDevice Silicon Valley on November 15-16, 2023, Santa Clara, CA. BIOMEDevice conferences bring engineers,[…]

Read more

Hydromer, Inc. Appoints New CEO

in Apr 25, 2023

Concord, NC, April 25, 2023 — Hydromer Inc. (OTC: HYDI), a worldwide supplier of specialty coatings and biopolymers for medical devices and industrial applications, announced today that Mr. Michael E. Torti has been appointed the new Chief Executive Officer of the company. Mr. Torti previously served Hydromer Inc. in the capacity of Vice President of[…]

Read more

Hydromer, Inc. Announces Removal of CEO

in Apr 06, 2023

CONCORD, NC, April 06, 2023 — Hydromer, INC. — The Board of Directors of Hydromer, Inc. (PINK: HYDI) voted to remove Peter von Dyck as Chief Executive Officer of the Company, effective March 24, 2023. Peter von Dyck served in the role of CEO since September 14, 2018 and led the Company through the economic[…]

Read more